Hemostasis Today

July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Arrigo Francesco Giuseppe Cicero: Redefining the Role of Urate-Lowering Therapy in Cardiovascular Disease
Jul 5, 2026, 17:31

Arrigo Francesco Giuseppe Cicero: Redefining the Role of Urate-Lowering Therapy in Cardiovascular Disease

Arrigo Francesco Giuseppe Cicero, Head and Associate Professor of Human Nutrition at Alma Mater Studiorum – University of Bologna and President at SiNut Official, shared a post on LinkedIn about a recent article he and his colleges co-authored published in European Heart Journal – Cardiovascular Pharmacotherapy, adding:

“I am pleased to share our latest review, published in European Heart Journal – Cardiovascular Pharmacotherapy:

‘Urate-lowering therapy in cardiovascular pharmacotherapy: from Mendelian randomization data to cardio–renal–metabolic risk modulation’

In this article, we discuss the role of serum uric acid and urate-lowering therapy within the broader cardio–renal–metabolic risk continuum, integrating epidemiological evidence, Mendelian randomization data, pharmacological considerations, and clinical trial findings.

Many thanks to Claudio Borghi and to Federica Fogacci for her outstanding ability to critically re-discuss an established argument.”

Title: Urate-lowering therapy in cardiovascular pharmacotherapy: from Mendelian randomization data to cardio–renal–metabolic risk modulation

Authors: Claudio Borghi, Federica Fogacci, Arrigo F G Cicero

Arrigo Francesco Giuseppe Cicero: Redefining the Role of Urate-Lowering Therapy in Cardiovascular Disease

Stay updated on all scientific advances with Hemostasis Today.